Hu'an Medical Technology Co., Ltd. (stock code: 6657), a company in the biotechnology and medical industry, has released its financial report for the first quarter of 2026. The company recorded a basic earnings per share (EPS) of -0.53 TWD. Total operating revenue for the quarter was 10 million TWD (0.01 billion TWD), while the net profit after tax stood at -46 million TWD, reflecting a substantial net loss for the period. This performance suggests significant challenges or intensive R&D investments typical of companies in this sector, pointing towards a strategy focused on future innovation and market penetration rather than immediate profitability.

FACT BOX

  • Source: PR Times
  • Category: 財報
  • Products / services: Biotechnology products / Medical devices